Advanced Search

 

Study ID Status Title Patient Level Data
SUM10931 Completed Evaluation of the pharmacokinetics and safety of ascending oral doses of GR43175C administered to healthy male volunteers.
SUM10933 Completed Tolerance assessment of daily subcutaneous (sc) GR43175C.
SUM10935 Completed Evaluation of the pharmacokinetics and safety of ascending doses of GR43175C administered subcutaneously to healthy male volunteers.
SUM10948 Completed An open, randomised, single-dose, three-way crossover, pilot study investigating the relative bioavailability of two newly formulated fast disintegrating sumatriptan 50mg tablets versus the currently marketed sumatriptan 50mg tablets in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
SUM10950 Completed An open, randomised, four-period crossover study to demonstrate the bioequivalence of fast disintegrating sumatriptan tablets (50 and 100 mg tablets) compared with the currently marketed sumatriptan tablets (50 and 100 mg IMITREX† /IMIGRAN† tablets), in healthy male and female volunteers Study Listed on ClinicalStudyDataRequest.com
SUM10954 Completed An open, randomised, three-period crossover study to demonstrate the bioequivalence of fast disintegrating sumatriptan 100mg tablet compared to the currently marketed sumatriptan 100mg tablet administered immediately after food and the fast disintegrating tablet administered in the fasted state to healthy male and female subjects Study Listed on ClinicalStudyDataRequest.com
SUM10955 Completed An open, randomised, four-period crossover study to investigate the bioavailability of a new orally disintegrating (melt) formulation (ODT) of sumatriptan, with and without water compared to the currently marketed sumatriptan 100mg tablet and also to investigate the effect of food on the ODT formulation, in healthy male and female subjects Study Listed on ClinicalStudyDataRequest.com
SUM10961 Completed An open, randomised, two-period crossover study to demonstrate the bioequivalence of fast disintegrating sumatriptan 100 mg tablet dissolved in water compared to the currently marketed sumatriptan 100 mg tablet administered in the fasted state to healthy male and female subjects Study Listed on ClinicalStudyDataRequest.com
SUM10965 Completed Bioequivalence study between sumatriptan succinate kit product (STATdose™) and ampoule product in healthy Japanese male subjects
SUM20005 Completed A double-blind, placebo-controlled, randomised, parallel group study to evaluate 5 dose levels of sumatriptan suppositories (6, 12.5, 25, 50 and 100mg) in the acute treatment of migraine.
SUM20006 Completed A study to compare the pharmacokinetics of single oral and subcutaneous doses of sumatriptan in patients with hepatic impairment and in healthy subjects.
SUM20007 Completed Safety and efficacy of three doses of GR43175C in acute migraine treatment.
SUM20008 Completed Dose range trial of oral GR43175C in migraine patients.
SUM20018 Completed The acute treatment of migraine with subcutaneous GR43175C. A placebo-controlled study.
SUM20025 Completed A double-blind, placebo-controlled, parallel group study to evaluate four dose levels of sumatriptan intranasal (2.5, 5, 10, 20mg) in the acute treatment of migraine.
SUM20026 Completed A double-blind, placebo-controlled study to evaluate intranasal GR43175N (1, 5, 10, 20 and 40mg) in the acute treatment of migraine (two-nostril application).
SUM20027 Completed A double-blind, placebo-controlled study to evaluate intranasal GR43175N (1mg, 5mg, 10mg, 20mg and 40mg) in the acute treatment of migraine (one nostril application).
SUM20033 Completed A Randomised, Double-Blind, Placebo-Controlled, In-Clinic Pilot Study To Investigate The Efficacy And Tolerability Of 100mg Sumatriptan Administered As A Film-Coated, Fast Disintegrating Tablet Study Listed on ClinicalStudyDataRequest.com
SUM20040 Completed An open-label, randomised, two-period, crossover study to assess the safety, tolerability and pharmacokinetics of the 3 mg STATdose administered two hours after a single IMITREX 100 mg tablet relative to two 6 mg STATdose injections administered one hour apart in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
SUM30009 Completed A single centre, placebo-controlled, double blind, randomised cross-over, single attack study evaluating the efficacy and tolerability of sumatriptan nasal spray 10mg for the acute treatment of migraine in children suffering from refractory migraine with/without aura.
SUM30011 Completed A Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sumatriptan Suppositories in the Acute Treatment of a Single Migraine Attack.
SUM30013 Completed A randomised, double-blind, cross-over study to compare the efficacy and safety of sumatriptan 25mg suppository with cafergot suppository (2mg ergotamine tartrate, 100mg caffeine) (one suppository plus option of one additional suppository) in the acute treatment of migraine.
SUM30014 Completed A double-blind, placebo-controlled, parallel-group study to evaluate two dose levels of sumatriptan suppository (12.5mg and 25mg) in the acute treatment of migraine attack, with an optional repeat dose for headache recurrence.
SUM30015 Completed A double-blind, placebo-controlled cross-over study to evaluate the acute effects of subcutaneous GR43175C (6mg) in cluster headache.
SUM30017 Completed A double-blind study to compare oral GR43175C (100mg) with oral aspirin (900mg) and metoclopramide (10mg) in the acute treatment of migraine.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.